E-LIB Suche - Ergebnisse für: Ichikawa, W.

1

482P Blood-based oxidative phosphorylation-related gene sig..:

Inagaki, C. ; Matoba, R. ; Lijuma, H....
Annals of Oncology. 35 (2024) - p. S192 , 2024

Link: https://doi.org/10.1016/..

2

38P Modified (m)-FOLFOXIRI plus cetuximab versus bevacizuma..:

Sunakawa, Y. ; Shiozawa, M. ; Kawai, T....
Annals of Oncology. 35 (2024) - p. S20 , 2024

Link: https://doi.org/10.1016/..

3

Ramucirumab plus FOLFIRI as second-line treatment for patie..:

Yasui, H. ; Okita, Y. ; Nakamura, M....
ESMO Open. 8 (2023) 5 - p. 101636 , 2023

Link: https://doi.org/10.1016/..

4

Dynamic changes in RAS gene status in circulating tumour DN..:

Sunakawa, Y. ; Satake, H. ; Usher, J....
ESMO Open. 7 (2022) 3 - p. 100512 , 2022

Link: https://doi.org/10.1016/..

5

CXCR4 polymorphism predicts progression-free survival in me..:

Matsusaka, S ; Cao, S ; Hanna, D L...
The Pharmacogenomics Journal. 17 (2016) 6 - p. 543-550 , 2016

Link: https://doi.org/10.1038/..

6

A genetic variant in Rassf1a predicts outcome in mCRC patie..:

Sebio, A ; Stintzing, S ; Heinemann, V...
The Pharmacogenomics Journal. 18 (2016) 1 - p. 43-48 , 2016

Link: https://doi.org/10.1038/..

7

An internally and externally validated nomogram for predict..:

Ichikawa, W ; Uehara, K ; Minamimura, K...
British Journal of Cancer. 112 (2015) 10 - p. 1709-1716 , 2015

Link: https://doi.org/10.1038/..

8

2010 A genetic variant in RASSF1A, a key regulator of HIPPO..:

Sebio, A. ; Stintzing, S. ; Heinemann, V....
European Journal of Cancer. 51 (2015) - p. S331 , 2015

Link: https://doi.org/10.1016/..

9

2100 Impact of UGT1A1 genotype and irinotecan exposure on o..:

Ichikawa, W. ; Uehara, K. ; Minamimura, K....
European Journal of Cancer. 51 (2015) - p. S362 , 2015

Link: https://doi.org/10.1016/..

10

Phase II trial of combination therapy of gemcitabine plus a..:

Matsuyama, Masato ; Ishii, H. ; Furuse, J....
Investigational New Drugs. 33 (2014) 2 - p. 490-495 , 2014

Link: https://doi.org/10.1007/..

11

Regimen Selection for First-line FOLFIRI and FOLFOX Based o..:

Ishida, H. ; Fujita, K.-i. ; Akiyama, Y....
Japanese Journal of Clinical Oncology. 41 (2011) 5 - p. 617-623 , 2011

Link: https://doi.org/10.1093/..

12

The Unanswered Question: What Is the Determinant of S-1 Pha..:

Ichikawa, W ; Fujita, K ; Sasaki, Y
Clinical Pharmacology & Therapeutics. 84 (2008) 2 - p. 203-203 , 2008

Link: https://doi.org/10.1038/..

13

Simple and reliable technique for local resection of early ..:

Nihei, Z ; Ichikawa, W ; Osanai, T...
British Journal of Surgery. 83 (2005) 3 - p. 413-414 , 2005

Link: https://doi.org/10.1002/..

14

Expression of cyclooxygenase-2 (COX-2) mRNA in human colore..:

Hasegawa, K ; Ichikawa, W ; Fujita, T...
European Journal of Cancer. 37 (2001) 12 - p. 1469-1474 , 2001

Link: https://doi.org/10.1016/..

15

Comparison by carcinoembryonic antigen doubling time of hep..:

Ichikawa, W. ; Nihei, Z. ; Kawamura, N....
Surgical Oncology. 4 (1995) 5 - p. 271-276 , 1995

Link: https://doi.org/10.1016/..